These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Ensuring the right PET scan for the right patient. Spiro SG; Buscombe J; Cook G; Eisen T; Gleeson F; O'Brien M; Peake MD; Rowell NP; Seymour R Lung Cancer; 2008 Jan; 59(1):48-56. PubMed ID: 17850919 [TBL] [Abstract][Full Text] [Related]
6. When is it best to repeat a 2-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography scan on patients with non-small cell lung cancer who have received neoadjuvant chemoradiotherapy? Cerfolio RJ; Bryant AS Ann Thorac Surg; 2007 Oct; 84(4):1092-7. PubMed ID: 17888953 [TBL] [Abstract][Full Text] [Related]
7. [Surgery and adjuvant therapy in non-small-cell lung carcinoma (NSCLC). (stage I through operable stage IIIA)]. Eberhardt W; Fietkau R; Griesinger F; Passlick B; Stuschke M Onkologie; 2006 Sep; 29 Suppl 2():7-10. PubMed ID: 16974121 [No Abstract] [Full Text] [Related]
8. Usefulness of supraclavicular ultrasonography in the staging of lung cancer. Monsó E; Montserrat JM; Abad J; Texidó A; Roig J; Morera J Lung; 1992; 170(4):243-4. PubMed ID: 1326064 [No Abstract] [Full Text] [Related]
9. Getting the lowdown on lung cancer. Kreamer KM Nursing; 2003 Nov; 33(11):36-42; quiz 42-3. PubMed ID: 14597813 [No Abstract] [Full Text] [Related]
11. Clinical practice. Lung cancer screening. Mulshine JL; Sullivan DC N Engl J Med; 2005 Jun; 352(26):2714-20. PubMed ID: 15987920 [No Abstract] [Full Text] [Related]
12. Does computed tomography or positron emission tomography response after neoadjuvant chemotherapy for resectable non-small-cell lung cancer predict survival? Patz EF J Clin Oncol; 2008 Oct; 26(28):4542-3. PubMed ID: 18824705 [No Abstract] [Full Text] [Related]
13. Advanced non-small cell lung cancer: current state of knowledge. ONS News; 2004; 19(9 Suppl):41-2. PubMed ID: 15478581 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of lung cancer]. Tomita M Gan No Rinsho; 1989 Jan; Spec No():128-37. PubMed ID: 2536852 [No Abstract] [Full Text] [Related]
15. [What's new in lung cancer]. Letonturier P Presse Med; 2007 Mar; 36(3 Pt 1):441-3. PubMed ID: 17436450 [No Abstract] [Full Text] [Related]
16. Scalpels, beams, drugs, and dreams: challenges of stage IIIA-N2 non-small-cell lung cancer. Johnson DH; Rusch VW; Turrisi AT J Natl Cancer Inst; 2007 Mar; 99(6):415-8. PubMed ID: 17374824 [No Abstract] [Full Text] [Related]
17. Modification and implementation of NCCN guidelines on non-small cell lung cancer in the Middle East and North Africa region. Jazieh AR; Bamefleh H; Demirkazik A; Gaafar RM; Geara FB; Javaid M; Khader J; Khodadad K; Omar W; Saadeddin A; Sabe HA; Shadmehr MB; El Sherif A; Uddin N; Jahanzeb M; Ettinger D; J Natl Compr Canc Netw; 2010 Jul; 8 Suppl 3():S16-21. PubMed ID: 20697125 [TBL] [Abstract][Full Text] [Related]
18. [Role of (18)F-FDG PET for therapeutic monitoring in non-small-cell lung cancer]. Huang W; Wang J; Li BS Zhonghua Jie He He Hu Xi Za Zhi; 2010 Nov; 33(11):855-7. PubMed ID: 21211376 [No Abstract] [Full Text] [Related]